Received Mar 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
skin reaction the day following her own COVID vaccine in 2021 to a diagnosis of Psoriasis; This is a spontaneous report received from a Physician. A female patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Psoriasis" (ongoing). The patient's concomitant medications were not reported. The following information was reported: PSORIASIS (non-serious), outcome "unknown", described as "skin reaction the day following her own COVID vaccine in 2021 to a diagnosis of Psoriasis". Additional information: The reporter stated that a physician I met with stated she attributes a skin reaction the day following her own COVID vaccine in 2021 to a diagnosis of Psoriasis. She stated her vaccine was a Pfizer vaccine. Of note, she stated her Rheumatologist describes that after COVID infections, patients with Rheumatic diseases can no longer be managed with monotherapy immune modulation due to severity of immune disease. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
Psoriasis